Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Meningococcal disease: the organism, clinical presentation, and worldwide epidemiology.

Al-Tawfiq JA, Clark TA, Memish ZA.

J Travel Med. 2010 Sep-Oct;17 Suppl:3-8. doi: 10.1111/j.1708-8305.2010.00448.x. No abstract available.

2.

The risk of meningococcal disease in travelers and current recommendations for prevention.

Steffen R.

J Travel Med. 2010 Sep-Oct;17 Suppl:9-17. doi: 10.1111/j.1708-8305.2010.00449.x. No abstract available.

3.

Travelers' protection against meningococcal disease: a new vaccine option.

Black S.

J Travel Med. 2010 Sep-Oct;17 Suppl:18-25. doi: 10.1111/j.1708-8305.2010.00450.x. No abstract available.

4.

The epidemiology of meningococcal disease and the impact of vaccines.

Khatami A, Pollard AJ.

Expert Rev Vaccines. 2010 Mar;9(3):285-98. doi: 10.1586/erv.10.3. Review. Erratum in: Expert Rev Vaccines. 2011 Mar;10(3):398.

PMID:
20218857
5.

Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.

Popovic T, Sacchi CT, Reeves MW, Whitney AM, Mayer LW, Noble CA, Ajello GW, Mostashari F, Bendana N, Lingappa J, Hajjeh R, Rosenstein NE.

Emerg Infect Dis. 2000 Jul-Aug;6(4):428-9. No abstract available.

6.

Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000.

Cartwright K, Noah N, Peltola H; Meningococcal Disease Advisory Board.

Vaccine. 2001 Aug 14;19(31):4347-56. No abstract available.

PMID:
11534497
7.

Meningococcal disease and travel.

Memish ZA.

Clin Infect Dis. 2002 Jan 1;34(1):84-90. Epub 2001 Nov 20.

PMID:
11731951
8.

Meningococcal disease.

Memish ZA, Alrajhi AA.

Saudi Med J. 2002 Mar;23(3):259-64. Review.

PMID:
11938412
9.

Epidemiology and prevention of meningococcal disease.

Riedo FX, Plikaytis BD, Broome CV.

Pediatr Infect Dis J. 1995 Aug;14(8):643-57. Review. No abstract available.

PMID:
8532420
10.

Meningococcal disease and prevention at the Hajj.

Borrow R.

Travel Med Infect Dis. 2009 Jul;7(4):219-25. doi: 10.1016/j.tmaid.2009.05.003. Epub 2009 Jun 24.

PMID:
19717104
11.

Prevention of invasive meningococcal disease in the United States.

Pelton SI.

Pediatr Infect Dis J. 2009 Apr;28(4):329-32. doi: 10.1097/INF.0b013e3181a2d6b5. Review. No abstract available.

PMID:
19333079
12.

Meningococcal disease and travel.

Wilder-Smith A, Memish Z.

Int J Antimicrob Agents. 2003 Feb;21(2):102-6. Review.

PMID:
12615371
13.

Fulminant supraglottitis from Neisseria meningitidis.

Kortepeter MG, Adams BL, Zollinger WD, Gasser RA Jr.

Emerg Infect Dis. 2007 Mar;13(3):502-4. No abstract available.

14.

Meningococcal disease and vaccination in North America.

Pollard AJ, Scheifele D.

J Paediatr Child Health. 2001 Oct;37(5):S20-7.

PMID:
11885732
15.

Meningococcal vaccines: WHO position paper, November 2011.

[No authors listed]

Wkly Epidemiol Rec. 2011 Nov 18;86(47):521-39. English, French. No abstract available.

16.

The epidemiology and control of invasive meningococcal disease.

Diaz PS.

Pediatr Infect Dis J. 1999 Jul;18(7):633-4. Review. No abstract available.

PMID:
10440442
17.

Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj.

Husain EH, Dashti AA, Electricwala QY, Abdulsamad AM, Al-Sayegh S.

Med Princ Pract. 2010;19(4):321-3. doi: 10.1159/000312721. Epub 2010 May 26.

18.

Serogroup W-135 meningococcal disease among travelers returning from Saudi Arabia--United States, 2000.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2000 Apr 28;49(16):345-6.

19.

W135 meningococcal carriage in association with the Hajj pilgrimage 2001: the Singapore experience.

Wilder-Smith A.

Int J Antimicrob Agents. 2003 Feb;21(2):112-5.

PMID:
12615373
20.

Supplemental Content

Support Center